Am Soc of Clinical Oncology discussing alternative medicine May 1999 ASCO/ACS Symposium on Integrative Medicine, 2001 ASCO CAM 2002 CAM-Viewpoint of Wendy S. Harpham, MD ASCO CAM 2005 Various reports Atlanta, 6/06 Patient/Physician Communication on Treatment/Prognosis Abstracts from ASCO 2006 Effect of Lifestyle Factors on Breast Ca Prognosis Studies presented quality of life and more Study on Testicular Cancer Survivors Photodynamic Therapy-Head/Neck Tamoxifen and ER- Tumors Am Soc of Clinical Oncology #1628 Use of Herbal & Vitamin Therapies in Adult Cancer Pts #1622 Long Term Adjustment of Survivors of Early Stage Bca (20 yrs) #1484 Girls at Higher Risk for 2nd Malignancies than Boys? #1967 Survival of Metastatic Bca Pts at Integrative Medicine Clinic #1606 Topical NAC to Reduce Severity of Oral Mucositis #260 Gamma Linolenic Acid as Radiation Response Modifier #2995 Differences In Psychological Functioning Using CAM #2996 Hot Flashes and Acupuncture #1542 Goal of Chemotherapy: Little Agreement Between Pts and Docs #3115 Strategies To Identify Herbal Compounds for Clinical Trials #2529 Prospective Look at In Vitro Assay Determining Chemos #970 Survey of Modalities of Toxicity Assessement/Reporting Variety of articles and abstracts May 18-21, 2002 Orlando, FL Tech Assess:Aromatase Inhib (Adjuvant) FDA Presents: Tamoxifen & Uterine Sarcoma Survival/QOL: Advanced Pancreatic Ca 9-cis retin acid vs 13-cis+alpha-tocoph vs placebo Pts Who Smoke w/ Chemo/Rads Zolendronic Acid & Mets from Solid Tumors Use of CAM in Phase I Clinical Trials Pregnancy :Lymphoma Pt Not Adverse Prognosis Unwanted Results:Failure to Publish Operational Bias in Assessing Time to Progression (TTP) New York TImes, 5/28/02 Re ASCO 2002 Various abstracts Am Society for Clinical Oncology Phenoxodiol, a Naturally Occurring Isoflavinoid Phase 1 Trial of Flavopiridol & Chemo Phase 1 Study of Bryostatin-1 & Gemcitabine Amifostine to Prevent Xerostomia of Head/Neck RTX CAM Among Cancer Patients Accelerated FDA Approval Assoc w/Later ID Adverse Effects Excessive Tearing & Canalicular Blockage:Docetaxel Under 35 Breast Cancer in Turkey Abnormal Regional Brain Metabolism After Chemo Outcome: Invas Lobular w/Inv Ductal Update on Royal Marsden Tamoxifen Prevention Trial 6/04 Excerpts from Ralph Moss' Report on ASCO, 2004 Yondelis - 'novel' marine-derived anti-tumor agent Children w/ALL Deficient in Antioxidant Vitamins Finasteride: Cost-effectiveness/Lifetime Implications Abstracts from ASCO, 2004 Various abstracts and articles Integrative Cancer Care: Development of Therapeutic Paradigm Identification of Retrovirus in Human Breast Cancer Meeting in Chicago, June 2007 many abstracts, press releases, articles Anthracyclines & Topoll-2 8% of Users Benefit (BCa) Ralph Moss Reports on ASCO 2007 Ann Fonfa's Comments on CAM meeting at ASCO 2007 Aminoglycoside-induced deafness in leukemic patients Ginseng May Help Ease Fatigue Less Intense Treatment for Advanced Neuroblastoma Achieves High Survival Rates Flaxseed May Delay Prostate Cancer Growth Avemar increased Effect of Tamoxifen on MCF7 (ER+) Cells Afr Am Fare Worse Bevacizumab (Avastin) Colorectal Ca Study Remember we are NOT Doctors and have NO medical training. This site is like an Encylopedia - there are many pages, many links on many topics. Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.